Weekly Insider Report: Biotech and Medical Stocks


This insider buying report is posted on BHI once a week. BHI does not take any responsibility for any financial loss or damage caused by or related to the following report. The following information should be used for entertainment purposed only.

Last week's report


This week's report:

BIOTECH
bought Dynavax Tech [DVAX]: Oct 4, $4.40 by Beneficial Owner
bought NeoPHARM [NEOL]: Oct 10-12, $6.64-$7.20 by Director
bought MacroChem Corp [MACM]: Oct 10-11, $0.52 by Officer
sold Amylin Pharm [AMLN]: Oct 9, $45.00 by Officer
sold Digene Corp [DIGE]: Oct 10, $45.00-$45.38 by 2 Directors
sold Harvard Bioscience [HBIO]: Oct 6, $4.42-$4.43 by 2 Beneficial Owners
sold Imclone Systems [IMCL]: Oct 10, $30.92 by Officer
sold Isis Pharm [ISIS]: Oct 6, $7.95-$8.00 by Officer



DRUGS
bought Iomai Corp [IOMI]: Oct 6-11, $4.95-$5.47 by Director
sold Conor Medsystems [CONR]: Oct 4, $25.00 by Officer
sold United Therapeutics [UTHR]: Oct 5, $51.01-$51.54 by 3 Officers
sold Somaxon Pharm [SOMX]: Oct 5-6, $12.57-$13.15 by 2 Officers



MEDICAL SUPPLIES
bought Synovis Life Tech [SYNO]: Oct 4, $7.00 by Officer
bought Emergency Filtration Products [EMFP]: Oct 5, $0.88 by Beneficial Owner
sold Abaxis [ABAX]: Oct 5, $25.07 by Officer
sold Foxhollow Tech [FOXH]: Oct 9, $34.20-$34.26 by Officer
sold Wright Medical Grp [WMGI]: Oct 11-12, $23.15-$23.47 by Officer
sold Arrow Int [ARRO]: Oct 11-12, $33.65-$34.02 by Director
sold Nastech Pharm [NSTK]: Oct 9-10, $15.60-$16.00 by Director & Officer


_